Amedisys (AMED) PT Raised to $133 at RBC Capital
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Amedisys (AMED) PT Raised to $136 at UBS
March 1, 2019 6:58 AM ESTUBS raised its price target on Amedisys (NASDAQ: AMED) to $136.00 (from $126.00) while maintaining a Neutral rating.
... MoreAmedisys (AMED) PT Raised to $140 at Oppenheimer
February 28, 2019 4:17 PM ESTOppenheimer analyst Michael Wiederhorn raised the price target on Amedisys (NASDAQ: AMED) to $140.00 (from $137.00) while maintaining a Outperform rating.
... MoreAmedisys (AMED) PT Lowered to $124 at Craig-Hallum
February 28, 2019 3:52 PM ESTCraig-Hallum analyst Kevin Ellich lowered the price target on Amedisys (NASDAQ: AMED) to $124.00 (from $132.00) while maintaining a Hold rating.
Ellich notes FY19 guidance was lower partially due to CCH integration.
... More